相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
Conan G. Kinsey et al.
NATURE MEDICINE (2019)
Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression
Margie N. Sutton et al.
CANCERS (2019)
The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts
Weiqun Mao et al.
CANCER (2019)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
ALK in Neuroblastoma: Biological and Therapeutic Implications
Ricky M. Trigg et al.
CANCERS (2018)
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond
Nina Prokoph et al.
CANCERS (2018)
Directed Therapies in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
Ralph L. Millett et al.
ANTICANCER RESEARCH (2018)
Venetoclax for the treatment of chronic lymphocytic leukemia
Massimo Gentile et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors
Cynthia I. Chude et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features
Kentaro Inamura
CANCERS (2017)
Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents
Ciska Verbaanderd et al.
ECANCERMEDICALSCIENCE (2017)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement
Shaoxian Tang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Mechanisms of Cancer Cell Dormancy-Another Hallmark of Cancer?
Albert C. Yeh et al.
CANCER RESEARCH (2015)
The role for autophagy in cancer
Eileen White
JOURNAL OF CLINICAL INVESTIGATION (2015)
ARHI (DIRAS3)-mediated autophagy-associated cell death enhances chemosensitivity to cisplatin in ovarian cancer cell lines and xenografts
M. N. Washington et al.
CELL DEATH & DISEASE (2015)
Crizotinib induces autophagy through inhibition of the STAT3 pathway in multiple lung cancer cell lines
Liangkun You et al.
ONCOTARGET (2015)
Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
Kate McKeage
DRUGS (2015)
DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells
Zhen Lu et al.
AUTOPHAGY (2014)
ARHI (DIRAS3) induces autophagy in ovarian cancer cells by downregulating the epidermal growth factor receptor, inhibiting PI3K and Ras/MAP signaling and activating the FOXo3a-mediated induction of Rab7
Z. Lu et al.
CELL DEATH AND DIFFERENTIATION (2014)
ARHI Overexpression Induces Epithelial Ovarian Cancer Cell Apoptosis and Excessive Autophagy
Jie Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Self-consumption: the interplay of autophagy and apoptosis
Guillermo Marino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Over-expression of ARHI decreases tumor growth, migration, and invasion in human glioma
Jing Chen et al.
MEDICAL ONCOLOGY (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer REPLY
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
STAT3 Target Genes Relevant to Human Cancers
Richard L. Carpenter et al.
CANCERS (2014)
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Hua Yu et al.
NATURE REVIEWS CANCER (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer
Wenxing Chen et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Three-dimensional cell culturing by magnetic levitation
William L. Haisler et al.
NATURE PROTOCOLS (2013)
The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms
Zhen Lu et al.
CELL ADHESION & MIGRATION (2013)
Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer
Hong Ren et al.
CANCER RESEARCH (2012)
Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target
Leena Gandhi et al.
CLINICAL CANCER RESEARCH (2012)
Life in the balance - a mechanistic view of the crosstalk between autophagy and apoptosis
Assaf D. Rubinstein et al.
JOURNAL OF CELL SCIENCE (2012)
The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways
D. B. Badgwell et al.
ONCOGENE (2012)
ARHI (DIRAS3), an imprinted tumour suppressor gene, binds to importins and blocks nuclear import of cargo proteins
Shaoyi Huang et al.
BIOSCIENCE REPORTS (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
Hao Min et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors
Michael S. Anglesio et al.
MOLECULAR CANCER RESEARCH (2008)
Apoptosis and autophagy: regulatory connections between two supposedly different processes
Andrew Thorburn
APOPTOSIS (2008)
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors
Irene Dalai et al.
NEOPLASIA (2007)
Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer
Z Lu et al.
CLINICAL CANCER RESEARCH (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: A non-randomized comparison using an explanatory analysis: A Gynecologic Oncology Group study
BE Greer et al.
GYNECOLOGIC ONCOLOGY (2005)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers
RZ Luo et al.
ONCOGENE (2003)
分享论文
